News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-08-07 4:1:47 am Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update GlobeNewsWire
2023-08-01 4:53:29 am Investing in Aclaris Therapeutics (NASDAQ:ACRS) three years ago would have delivered you a 363% gain Simply Wall St.
2023-07-06 5:19:0 am Calliditas Therapeutics AB Sponsored ADR (CALT) Moves 12.8% Higher: Will This Strength Last? Zacks
2023-06-26 7:15:0 am 2 Low-Priced Stocks That Could Make You Richer Motley Fool
2023-06-13 3:30:31 pm Why Aclaris Therapeutics Topped the Market on Tuesday Motley Fool
2023-06-13 4:1:0 am Aclaris Therapeutics Completes Enrollment in Phase 2b Study of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis (ATI-450-RA-202) GlobeNewswire
2023-06-02 4:0:0 am Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences GlobeNewswire
2023-05-18 10:50:51 am Top Pharmaceutical Stocks for Q2 2023 Investopedia
2023-05-10 3:4:5 am Aclaris Therapeutics First Quarter 2023 Earnings: Beats Expectations Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information